Inhibikase Therapeutics, Inc. - Common Stock (NQ:IKT)

2.105 +0.125 (+6.31%)
Streaming Delayed Price Updated: 12:57 PM EDT, Jul 7, 2026 Add to My Watchlist

Price and Volume

Detailed Quote
Volume 653,895
Open 1.980
Bid (Size) 2.100 (3,900)
Ask (Size) 2.110 (1,100)
Prev. Close 1.980
Today's Range 1.970 - 2.120
52wk Range 1.330 - 2.260
Shares Outstanding 31,056,238
Dividend Yield N/A

Performance

YTD
+7.9%
+7.9%
1 Month
+29.9%
+29.9%
3 Month
+17.6%
+17.6%
6 Month
+4.7%
+4.7%
1 Year
+9.1%
+9.1%

More News

Read More

Frequently Asked Questions

Is Inhibikase Therapeutics, Inc. - Common Stock publicly traded?
Yes, Inhibikase Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Inhibikase Therapeutics, Inc. - Common Stock trade on?
Inhibikase Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Inhibikase Therapeutics, Inc. - Common Stock?
The ticker symbol for Inhibikase Therapeutics, Inc. - Common Stock is IKT on the Nasdaq Stock Market
What is the current price of Inhibikase Therapeutics, Inc. - Common Stock?
The current price of Inhibikase Therapeutics, Inc. - Common Stock is 2.105
When was Inhibikase Therapeutics, Inc. - Common Stock last traded?
The last trade of Inhibikase Therapeutics, Inc. - Common Stock was at 07/07/26 12:57 PM ET
What is the market capitalization of Inhibikase Therapeutics, Inc. - Common Stock?
The market capitalization of Inhibikase Therapeutics, Inc. - Common Stock is 65.37M
How many shares of Inhibikase Therapeutics, Inc. - Common Stock are outstanding?
Inhibikase Therapeutics, Inc. - Common Stock has 65M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.